Among the AAV patients with ocular disease followed at the Mayo Clinic from 2003 to 2013, 64% were PR3-ANCA(+), 21% were MPO-ANCA(+) and 15% tested negative for ANCA [64]. The gene discussed is PRTN3; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.